company background image
3613 logo

Beijing Tong Ren Tang Chinese Medicine Informe acción SEHK:3613

Último precio

HK$8.06

Capitalización de mercado

HK$6.7b

7D

-2.7%

1Y

-35.0%

Actualizada

18 Nov, 2024

Datos

Finanzas de la empresa +

Beijing Tong Ren Tang Chinese Medicine Company Limited

Informe acción SEHK:3613

Capitalización de mercado: HK$6.7b

Resumen de acción 3613

Beijing Tong Ren Tang Chinese Medicine Company Limited, junto con sus filiales, se dedica a la fabricación, venta al por menor y al por mayor de productos sanitarios y medicina china a mayoristas y particulares. Saber más

Análisis fundamental de 3613
Puntuación del snowflake
Valoración1/6
Crecimiento futuro3/6
Rendimiento pasado1/6
Salud financiera5/6
Dividendos4/6

Competidores de Beijing Tong Ren Tang Chinese Medicine Company Limited

Historial de precios y rendimiento

Resumen de todos los máximos históricos, cambios y caídas de precios de Beijing Tong Ren Tang Chinese Medicine
Precios históricos de las acciones
Precio actual de la acciónHK$8.06
Máximo en las últimas 52 semanasHK$13.44
Mínimo de 52 semanasHK$7.03
Beta0.47
1Cambio en 1 mes-3.70%
Variación en 3 meses-7.89%
Cambio de 1 año-35.00%
3Variación en 3 años-19.32%
Variación en 5 años-20.20%
Variación desde la OPV23.43%

Noticias y actualizaciones recientes

Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Shares Climb 32% But Its Business Is Yet to Catch Up

Oct 04
Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Shares Climb 32% But Its Business Is Yet to Catch Up

Earnings Troubles May Signal Larger Issues for Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Shareholders

Sep 06
Earnings Troubles May Signal Larger Issues for Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Shareholders

Recent updates

Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Shares Climb 32% But Its Business Is Yet to Catch Up

Oct 04
Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Shares Climb 32% But Its Business Is Yet to Catch Up

Earnings Troubles May Signal Larger Issues for Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Shareholders

Sep 06
Earnings Troubles May Signal Larger Issues for Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Shareholders

Is There An Opportunity With Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 31% Undervaluation?

Sep 02
Is There An Opportunity With Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 31% Undervaluation?

Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 28% Share Price Plunge Could Signal Some Risk

Feb 05
Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 28% Share Price Plunge Could Signal Some Risk

Calculating The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

Jan 03
Calculating The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

A Look At The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

Sep 28
A Look At The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

Here's Why We Think Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Might Deserve Your Attention Today

Jul 12
Here's Why We Think Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Might Deserve Your Attention Today

Is Now The Time To Put Beijing Tong Ren Tang Chinese Medicine (HKG:3613) On Your Watchlist?

Mar 29
Is Now The Time To Put Beijing Tong Ren Tang Chinese Medicine (HKG:3613) On Your Watchlist?

Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Has Announced That It Will Be Increasing Its Dividend To HK$0.28

Apr 28
Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Has Announced That It Will Be Increasing Its Dividend To HK$0.28

Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Will Pay A Larger Dividend Than Last Year At HK$0.28

Mar 25
Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Will Pay A Larger Dividend Than Last Year At HK$0.28

Are Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Investors Paying Above The Intrinsic Value?

Oct 27
Are Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Investors Paying Above The Intrinsic Value?

Beijing Tong Ren Tang Chinese Medicine's (HKG:3613) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 28
Beijing Tong Ren Tang Chinese Medicine's (HKG:3613) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares

Mar 11
Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares

What Type Of Returns Would Beijing Tong Ren Tang Chinese Medicine's(HKG:3613) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Feb 04
What Type Of Returns Would Beijing Tong Ren Tang Chinese Medicine's(HKG:3613) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Should Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Be Part Of Your Dividend Portfolio?

Jan 18
Should Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Be Part Of Your Dividend Portfolio?

Could The Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Ownership Structure Tell Us Something Useful?

Dec 29
Could The Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Ownership Structure Tell Us Something Useful?

Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares

Dec 11
Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares

Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Nov 23
Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Rentabilidad de los accionistas

3613HK PharmaceuticalsMercado HK
7D-2.7%-2.0%-2.7%
1Y-35.0%-9.4%10.9%

Rentabilidad vs. Industria: Los resultados de 3613 fueron inferiores a los de la industria Hong Kong Pharmaceuticals, que obtuvo un rendimiento del -9.4% el año pasado.

Rentabilidad vs. Mercado: 3613 obtuvo unos resultados inferiores a los del mercado Hong Kong, que fueron del 10.9% el año pasado.

Volatilidad de los precios

Is 3613's price volatile compared to industry and market?
3613 volatility
3613 Average Weekly Movement6.7%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement9.0%
10% most volatile stocks in HK Market19.0%
10% least volatile stocks in HK Market4.2%

Precio estable de las acciones: 3613 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de 3613 (7%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
1669779Wang Chiwww.tongrentangcm.com

Beijing Tong Ren Tang Chinese Medicine Company Limited, junto con sus filiales, se dedica a la fabricación, venta al por menor y al por mayor de productos sanitarios y medicina china a mayoristas y particulares. La empresa opera a través de tres segmentos: Hong Kong, China continental y ultramar. También ofrece servicios de consulta y tratamiento de medicina china.

Resumen de fundamentos de Beijing Tong Ren Tang Chinese Medicine Company Limited

¿Cómo se comparan los beneficios e ingresos de Beijing Tong Ren Tang Chinese Medicine con su capitalización de mercado?
Estadísticas fundamentales de 3613
Capitalización bursátilHK$6.75b
Beneficios(TTM)HK$494.14m
Ingresos (TTM)HK$1.38b

13.7x

Ratio precio-beneficio (PE)

4.9x

Ratio precio-ventas (PS)

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de 3613
IngresosHK$1.38b
Coste de los ingresosHK$384.69m
Beneficio brutoHK$991.96m
Otros gastosHK$497.83m
BeneficiosHK$494.14m

Últimos beneficios comunicados

Jun 30, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)0.59
Margen bruto72.06%
Margen de beneficio neto35.89%
Ratio deuda/patrimonio0.006%

¿Cómo se ha desempeñado 3613 a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

4.1%

Rentabilidad actual por dividendo

56%

Ratio de pagos